Trends, regional variation and clinical characteristics of recipients of antivirals and neutralising monoclonal antibodies for non-hospitalised COVID-19: a descriptive cohort study of 23.4 million people in OpenSAFELY

Green A., Curtis HJ., Higgins R., Smith R., Mehrkar A., Inglesby P., Mahalingasivam V., Drysdale H., DeVito NJ., Croker R., Rentsch CT., Bhaskaran K., Andrews C., Bacon S., Davy S., Dillingham I., Evans D., Fisher L., Hickman G., Hopcroft L., Hulme WJ., Nab L., Massey J., Morley J., Morton CE., Park R., Walker AJ., Ward T., Wiedemann M., Bates C., Cockburn J., Parry J., Hester F., Harper S., Douglas IJ., Evans SJW., Tomlinson L., MacKenna B., Goldacre B.

DOI

10.1101/2022.03.07.22272026

Type

Preprint

Publication Date

10/03/2022

Permalink Original publication